Medical Oncology and Hematology
The Brown Cancer Center’s approach to medical oncology is deeply rooted in the center’s translational research findings, which focus on highly-targeted therapies that dramatically reduce toxicity and harmful side-effects.
The center’s hemotology/oncology services include the combined strength of groundbreaking research, leading-edge technology, accomplished specialists and exceptional, collaborative care in, breast cancer, gastrointestinal cancers, genitor-urinary cancers, gynecologic cancers, head and neck cancers, lung cancer, melanoma, and both malignant and benign blood disorders.
The collaboration of clinicians from each of the treatment modalities, clinical researchers and basic-science researchers at the Brown Cancer Center provides the optimal platform for bringing new treatments into clinical use rapidly. The center’s patients are often among the first to benefit from new treatments through the robust clinical trial program.
Currently Brown Cancer Center has more than a dozen other treatments in varying stages of development which have shown the potential to become viable alternatives for treating cancer in the very near future.
Medical Oncology and Hematology
The Brown Cancer Center’s approach to medical oncology is deeply rooted in the center’s translational research findings, which focus on highly-targeted therapies that dramatically reduce toxicity and harmful side-effects.
The center’s hemotology/oncology services include the combined strength of groundbreaking research, leading-edge technology, accomplished specialists and exceptional, collaborative care in, breast cancer, gastrointestinal cancers, genitor-urinary cancers, gynecologic cancers, head and neck cancers, lung cancer, melanoma, and both malignant and benign blood disorders.
The collaboration of clinicians from each of the treatment modalities, clinical researchers and basic-science researchers at the Brown Cancer Center provides the optimal platform for bringing new treatments into clinical use rapidly. The center’s patients are often among the first to benefit from new treatments through the robust clinical trial program.
Currently Brown Cancer Center has more than a dozen other treatments in varying stages of development which have shown the potential to become viable alternatives for treating cancer in the very near future.